Small study aims to unravel Statins' muscle side effects
NCT ID NCT02908425
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 36 times
Summary
This study looks at how statins, common cholesterol-lowering drugs, affect the body's handling of a substance called HMB, which is linked to muscle health. Researchers will study 13 older adults (ages 65-80) who take statins, measuring HMB levels in blood and urine. The goal is to understand why statins can cause muscle loss and find ways to prevent it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELEVATED HMB EXCRETION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Texas A&M University CTRAL
College Station, Texas, 77845-4253, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Beta Hydroxymethyl butyrate (HMB)
What this could lead to
If successful, this research could point toward new ways to prevent muscle loss in older adults taking statins.
What could go wrong
This is a small, early-stage study with only 13 participants, focused on understanding metabolism rather than testing a treatment. Results may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.